Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: A randomized, placebo-controlled trial

Supportive Care in Cancer

Volumn 11, Issue 1, 2003, Pages 41-47

  Nottage, Michelle ^a   McLachlan, Sue Anne ^b   Brittain, Mary Anne ^a   Oza, Amit ^a   Hedley, David ^a   Feld, Ronald ^a   Siu, Lillian L ^a   Pond, Gregory ^a   Moore, Malcolm J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

5 Fluorouracil; Mucositis; Sucralfate; Treatment

Indexed keywords

FLUOROURACIL; FOLINIC ACID; PLACEBO; SUCRALFATE; ANTINEOPLASTIC ANTIMETABOLITE; ANTIULCER AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTHWASH; MUCOSA INFLAMMATION; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; MIDDLE AGED; MOUTH HYGIENE; MOUTH MUCOSA; ORAL DRUG ADMINISTRATION; PATHOLOGY; STOMATITIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTI-ULCER AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; DOUBLE-BLIND METHOD; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTHWASHES; PLACEBOS; STOMATITIS; SUCRALFATE; TREATMENT OUTCOME;

EID: 0037854684     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-002-0378-8     Document Type: Article

References (22)

1. Bubley GJ, Chapman B, Chapman SK, Crumpacker CS, Schnipper LE (1989) Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions. Antimicrob Agents Chemother 33:862-865
2. Carter DL, Hebert ME, Smink K, Leopold KA, Clough RL, Brizel DM (1999) Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers. Head Neck 21:760-766
3. de Gramont A, Bosset JF, Milan C, Rougier P, Bouche O, Etienne PL, Morvan F, Louvet C, Guillot T, Francois E, Bedenne L (1997) Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 15:808-815
4. Dodd MJ, Facione NC, Dibble SL, MacPhail L (1996) Comparison of methods to determine the prevalence and nature of oral mucositis. Cancer Pract 4:312-318
5. Epstein JB, Wong FL (1994) The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. Int J Radiat Oncol Biol Phys 28:693-698
6. Erlichman C, Fine S, Wong A, Elhakim T (1988) A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6:469-675
7. Ferraro JM, Mattern JQ 2nd (1984) Sucralfate suspension for stomatitis. Drug Intell Clin Pharm 18:153
8. Fidler P, Loprinzi CL, O'Fallon JR, Leitch JM, Lee JK, Hayes DL, Novotny P, Clemens-Schutjer D, Bartel J, Michalak JC (1996) Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 77:522-525
9. Johnson MR, Diasio RB (2001) Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil. Adv Enzyme Regul 41:151-157
10. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG (1989) A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. J Clin Oncol 7:425-432
11. Loprinzi CL, Cianflone SG, Dose AM, et al. (1990). A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 65:1879-1882
12. Loprinzi CL, Ghosh C, Camoriano J, Sloan J, Steen PD, Michalak JC, Schaefer PL, Novotny PJ, Gerstner JB, White DF, Hatfield AK, Quella SK (1997) Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol 15:1235-1238
13. Mahood DJ, Dose AM, Loprinzi CL, et al (1991) Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9:449-452
14. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL (1997) Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol 15:1239-1243
15. Meredith R, Salter M, Kim R, Spencer S, Weppelmann B, Rodu B, Smith J, Lee J (1997) Sucralfate for radiation mucositis: results of a double-blind randomized trial. Int J Radiat Oncol Biol Phys 37:275-279
16. O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ, Wieand HS (1997) Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15:246-250
17. Okuno SH, Woodhouse CO, Loprinzi CL, Sloan JA, LaVasseur BI, Clemens-Schutjer D, Swan D, Axvig C, Ebbert LP, Tirona MR, Michalak JC, Pierson N (1999) Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol 22:258-261
18. Pfeiffer P, Madsen EL, Hansen O, May O (1990) Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. A randomized, double-blind cross-over study. Acta Oncol 29:171-173
19. Shenep JL, Kalwinsky DK, Hutson PR, George SL, Dodge RK, Blankenship KR, Thornton D (1988) Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J Pediatr 113:758-763
20. Sloan JA, Loprinzi CL, Novotny PJ, Okuno S, Nair S, Barton DL (2000) Sex differences in fluorouracil-induced stomatitis. J Clin Oncol 18:412-420
21. Solomon MA (1986) Oral sucralfate suspension for mucositis. N Engl J Med 315:459-460
22. Spielberger RT, Stiff P, Emmanouilides C, Yanovich S, Bensinger W, Hedrick E, Noga S, Ziegler T, Keating A, Frankel S, Gentile T, Heard R, Yao B, Elhardt D (2001) Efficacy of recombinant human keratinocyte growth factor (rHuKGF) in reducing mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantion (auto-PBPCT) after radiation-based conditioning - results of a phase 2 trial (abstract). Proc Am Soc Clin Oncol 20:25a